A new study on COVID-19 will look at the long-term impact the virus has had on survivors.
Investigators from the Yale School of Medicine are looking for answers and decided to launch its nationwide study with several partners across the country. The project is funded by the Centers for Disease Control and Prevention.
It's called Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE).
“Every day we learn something new about COVID-19, often to find out that what we believed to be true last month is no longer the case,” Dr. Arjun Venkatesh, an associate professor in the Department of Emergency Medicine at the Yale School of Medicine and co-principal investigator at the Yale University site, said in the news release. “The INSPIRE registry provides the opportunity to elucidate broader patient-oriented and centered outcomes of COVID-19 and take a long-term view likely to define the legacy of this pandemic in the U.S.”
Dr. Erica Spatz, a preventative cardiologist and associate professor in the section of cardiovascular medicine, a health services researcher at the Center for Outcomes Research and Evaluation (CORE) at the Yale School of Medicine and co-principal investigator at Yale, said the disease needs to be studied because it will impact the world for many years to come.
“This disease will be with us for years to come and understanding the impact on the health of survivors will be essential to our understanding of how to treat it,” Spatz said in the news release. “We are working with a phenomenal group of researchers from across the country and with Hugo Health to put together a virtual community that will enable research participants to fully engage with us as partners to advance our understanding of the ongoing impact of COVID-19."
The study wants to study 3,600 survivors and 1,200 control subjects.
